Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

NCT04975698

Conditions
HIV Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Georgetown Washington D.C., District of Columbia, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northside Atlanta, Georgia, United States
View Trial Details
Completed

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

NCT05455931

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Colombia University Medical Center New York, United States
  • Inova Dwight and Martha Schar Cancer Institute Fairfax, Virginia, United States
View all 19 locations
View Trial Details
Completed

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

NCT03323151

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Carle Cancer Center Urbana, Illinois, United States
  • University of Kansas Overland Park, Kansas, United States
View all 14 locations
View Trial Details

Related conditions